| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers R > Headlines for Rochester Drug Cooperative, Inc. > News item |
Rochester Drug disclosure statement hearing rescheduled for Dec. 4
By Sarah Lizee
Olympia, Wash., Nov. 18 – Rochester Drug Cooperative, Inc.’s disclosure statement approval hearing has been adjourned to Dec. 4 from Nov. 20, according to a notice filed Tuesday with the U.S. Bankruptcy Court for the Western District of New York.
The notice said the company requested the adjournment because Rochester Drug and the Internal Revenue Service have agreed that a deadline for the IRS to respond to a section 505 motion and claim objection is now Dec. 1.
The company is a Rochester, N.Y.-based health care distributor. It filed bankruptcy on March 12, 2020 under Chapter 11 case number 20-20230.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.